Kamada Ltd

KMDA

Company Profile

  • Business description

    Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

  • Contact

    2 Holzman Street
    P.O. Box 4081
    Science Park
    Rehovot7670402
    ISR

    T: +972 89406472

    E: [email protected]

    https://www.kamada.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    374

Stocks News & Analysis

stocks

Earnings winners: WOW, WTC and FMG set the tone

The ASX companies that closed out earnings season with a bang.
stocks

Do dividends build or limit wealth creation?

In this episode of Investing Compass, we talk to James Gruber about why he dislikes dividend stocks.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,435.6015.100.16%
CAC 408,580.7540.18-0.47%
DAX 4025,284.264.76-0.02%
Dow JONES (US)48,977.92521.28-1.05%
FTSE 10010,910.5563.850.59%
HKSE26,630.54249.520.95%
NASDAQ22,668.21210.17-0.92%
Nikkei 22558,850.2796.880.16%
NZX 50 Index13,722.9752.260.38%
S&P 5006,878.8829.98-0.43%
S&P/ASX 2009,198.6016.900.18%
SSE Composite Index4,162.8816.250.39%

Market Movers